Willem Van Weperen

Willem van Weperen is an accomplished executive in the biotechnology sector, currently serving as the Chief Executive Officer of Pluvia Biotech, a company focused on developing oral pharmacological chaperones for Phenylketonuria treatment. With a strong background in both leadership and operational roles, Willem has held significant positions such as SVP International at Intercept Pharmaceuticals, SVP Head of Europe at MyoKardia, and Regional VP International at Amicus Therapeutics. Other notable roles include Chief Commercial Officer at Prosensa Therapeutics and CEO of to-BBB. Willem's education includes an MBA from NIMBAS and a Master's in Medical Biology from Utrecht University. Additionally, Willem acts as a mentor with The Termeer Foundation, emphasizing the mission to advance healthcare innovations.